Inhibitors | Comment | Organism | Structure |
---|---|---|---|
diisopropylfluorophosphate | - |
Cavia porcellus | |
p-bromophenacyl bromide | - |
Cavia porcellus | |
phenylmethylsulfonyl fluoride | - |
Cavia porcellus |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
63000 | - |
gel filtration | Cavia porcellus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H2O | Cavia porcellus | inactivation of the substrate which represents a wide variety of bioactivities, including hypotension, platelat activation, bronchoconstriction | ? | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Cavia porcellus | - |
- |
- |
Purification (Comment) | Organism |
---|---|
- |
Cavia porcellus |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
ascites | - |
Cavia porcellus | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
20.3 | - |
- |
Cavia porcellus |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
1-hexadecyl-2-acetyl-sn-glycerol-3-phosphocholine + H2O | i.e. PAF | Cavia porcellus | 1-hexadecyl-sn-glycerol-3-phosphocholine + acetate | - |
? | |
1-hexadecyl-2-glutaryl-sn-glycero-3-phosphocholine + H2O | - |
Cavia porcellus | 1-hexadecyl-glycero-3-phosphocholine + glutarate | - |
? | |
1-hexadecyl-2-succinyl-sn-glycero-3-phosphocholine + H2O | - |
Cavia porcellus | 1-hexadecyl-glycero-3-phosphocholine + succinate | - |
? | |
1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine + H2O | inactivation of the substrate which represents a wide variety of bioactivities, including hypotension, platelat activation, bronchoconstriction | Cavia porcellus | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
monomer | 1 * 63000, SDS-PAGE | Cavia porcellus |